Apple Reportedly Working On Noninvasive Diabetes Sensors

Apple reportedly working on noninvasive diabetes sensors

Apple is reportedly working on an initiative that may one day make diabetics' frequent and painful finger pricking a thing of the past.
The tech giant has a team of biomedical engineers working on sensors that will allow diabetics to monitor their blood sugar levels noninvasively, CNBC reported Wednesday. Diabetes is said to be one of the fastest growing diseases in the world, affecting one in 11 adults around the globe, according to the World Health Organization.
The efforts have been going on for at least five years, with Apple already conducting feasibility trials at clinics in the San Francisco Bay Area, sources told the business news channel.
In order to keep blood sugar levels in check, diabetics must give themselves multiple finger prick blood tests throughout the day. These tests can be time consuming and painful. But they're crucial -- if glucose levels get out of control, diabetics risk damage to their eyes, kidneys and heart.
Other tech companies have tried and so far failed to develop a testing procedure that avoids piercing the skin. Google said three years ago that it was working on contact lenses with sensors "so small they look like bits of glitter" to help diabetics monitor their glucose levels, but so far no product has been released.
Apple didn't immediately respond to a request for comment.
Updated at 5:50 p.m. PT Continue reading

Rate this article

Total 1 ratings

Diabetes Without Symptoms Is Still Diabetes

An estimated 24 million Americans have diabetes, but according to the CDC, one-quarter to one-third don’t know it. How can so many individuals be unaware that they have diabetes? Certainly, one major factor is the absence of symptoms. This is a hallmark of both prediabetes and the early stages of type 2 diabetes.
Signs and Symptoms
Both type 1 and type 2 diabetes share such symptoms as unquenchable thirst with frequent urination, unexpected weight loss, fatigue, extreme hunger and blurred vision.
Another symptom experienced by people with type 2 diabetes is increased frequency of infections and cuts, or bruises that do not heal quickly. The onset of symptoms tends to be more gradual for people with type 2 diabetes than for those with type 1.
The gradual nature of prediabetes—often a precursor to type 2 diabetes—can disguise actual diabetic symptoms and prevent early diagnosis. As a result, it is especially important for individuals who have some diabetes risk factors to be aware of the symptoms and to watch for their appearance.
The appearance of any of these symptoms is a good reason to see a health care professional.
Risk Factors
Diabetes, particularly type 2, has a hereditary component. If an individual with diabetes has a family member with the disease, that individual has an increased chance of developing it as well. Other major risk factors include smoking, being overweight or inactive, or having high cholesterol or high blood pressure.
Age, ethnicity (of European descent for type 1, and of African, Asian, Hispanic, American Indian or Pacific Islander descent fo Continue reading

Invokana diabetes drug faces Canadian class-action lawsuit

Jack Julian is a data journalist in the Halifax newsroom. This is a new position, and he's excited about it. He likes surprises in his stories. Email: [email protected] Twitter: @jackjulian
The diabetes drug Invokana, recently adopted by Nova Scotia's pharmacare program, is now the subject of a national class-action lawsuit.
Court documents filed at the Ontario Superior Court of Justice allege the drug can cause kidney damage or death in some of those who take it.
"We believe that Invokana is a very risky drug for kidney failure, and that the medical profession and users of the drug should be alerted to the dangers and consider very carefully whether they continue on Invokana," said Tony Merchant, the Regina-based lawyer whose company, Merchant Law Group, is behind the lawsuit.
The class action has not been certified. Merchant said he expects that to happen in the next six to seven months.
None of the allegations have been proven in court.
Under Nova Scotia law, the action must first be certified as a class action before it can proceed.
Invokana was created by the multinational drug company Janssen Inc., and was approved by Health Canada in May 2014.
The Nova Scotia government added Invokana to the province's pharmacare formulary on Sept. 1, the third province to do so after Ontario and Quebec.
Scarborough woman at centre of lawsuit
Invokana isn't the only diabetes drug before the Canadian courts.
Lawyers in Halifax argued Tuesday in Nova Scotia Supreme Court for the certification of a class action suit against the drug Avandia from GlaxoSmithKline. Avandia is an insulin s Continue reading

UK fifth highest in world for child type 1 diabetes

The UK ranks the fifth highest in the world for the rate of children diagnosed with type 1 diabetes, figures reveal.
Each year in the UK more than 24 in every 100,000 children aged 14 and younger are told that they have this form of diabetes, which must be treated with insulin.
Experts say it is unclear why the figure is so high.
Unlike type 2 diabetes, type 1 is not linked to obesity or lifestyle.
Genes do appear to play a role.
The government said it had introduced an "incentive scheme" to ensure that every child has the best care possible, along with regional networks to share expertise in children's diabetes care across the NHS.
The league table, based on estimates from the International Diabetes Federation, includes most countries - apart from a few African nations, where often the rate of type 1 incidence is unknown.
Of all the countries with data, only Finland, Sweden, Saudi Arabia and Norway have higher rates than the UK.
The UK rate is double that in France (12.2 per 100,000) and Italy (12.1 per 100,000).
UK charities Diabetes UK and the Juvenile Diabetes Research Foundation (JDRF) say it is vital that people are aware of the symptoms of type 1 diabetes because if left undiagnosed and untreated, it can lead to serious illness and even death.
A quarter of the 2,000 children a year who develop diabetes are only diagnosed once they are already seriously ill.
Increasingly common
Barbara Young, chief executive of Diabetes UK, said: "We do not fully understand why more children in the UK are developing type 1 diabetes than almost anywhere else in the world. But the fact Continue reading

The World Series Pitcher with Type 1 Diabetes

Brandon Morrow is an anchor among the relief pitchers for the Los Angeles Dodgers.
Brandon Morrow may find his blood sugar levels elevated like the speed of his fastball today. After all, it’s not uncommon for a pitcher to have a surge of adrenaline knowing he is going to pitch in the World Series.
Luckily for Morrow, a relief pitcher for the Los Angeles Dodgers who has Type 1 diabetes, he already has honed his blood sugar management so that it has becomes an almost subconscious routine. In multiple interviews over the years, the 11-year Major League veteran has described how he has learned through trial and error what works for him to be at peak performance when he takes the mound.
He hasn’t always been perfect. Diagnosed at 17, Morrow says he remembers feeling like he was going low once during a college game, a feeling he says can make for a “long inning”. He has studiously tried to avoid that over the years, and he does it by trying to stick to what works. This means, for example, he often adheres as closely as he can to a regular diet during the season, one that includes a complex-carb protein bar about an hour and a half before game-time.
sponsor
Although it is hard to find instances of Morrow complaining much about his Type 1 diabetes in interviews, one can imagine his blood sugar routine became a bit more complicated when he was converted from a starting pitcher to a reliever. He uses an insulin pump, but disconnects when he’s getting close to being called into the game, and checks his blood sugars during regular intervals before and throughout the game. Th Continue reading